Please assess the completion status of the following clinical trial:

Trial Title: Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 50+ years of age~* NVAMD (Wet) in one eye, early or intermediate dry-AMD in the fellow eye~* taking AREDS vitamins (or equivalent)~Exclusion Criteria:~* Central geographic atrophy~* Diabetic retinopathy~* Ocular surgery in the eye with dry-AMD (not including cataract IOL surgery)~* Underlying ocular pathology in the eye with dry-AMD (especially glaucoma, dense cataracts, and retinitis pigmentosa)

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).